Compared with placebo, both tirzepatide (HR 0.78, 95% CI 0.660.93) and the GLP-1RA class (HR 0.85, 95% CI 0.800.91) were associated with lower risk of MACE, with moderate heterogeneity (Q = 13.9 [ p = 0.126], 2 = 0.0040, I 2 = 35.26%)
J Vet Med Sci
An injection delivers it directly, avoiding the need for absorbtion from the stomach (see Pernicious anaemia) no guesswork, no barriers
It is projected to grow at a high CAGR in the near future because of many things, like a strong healthcare system, a lot of money spent on research and development, and a high kind two diabetes rate
May 13, 2025: Study Says More People Lose Weight on Zepbound Than Wegovy According to a new study that examined post-clinical trial data, people lost more weight on Zepbound than Wegovy
Richardson, S